Alcohol Related Disorders Clinical Trial
Official title:
Preventing Harm From Alcohol Use in Older Adults
Older persons who drink can be vulnerable to negative consequences of drinking. This trial aims to prevent harm from alcohol use in older adults through a program of screening and brief advice followed up with several health education phone calls.
Approximately 50% of persons aged 65 years and older drink alcohol. Older persons are
particularly susceptible to adverse consequences of drinking such as falls, depression,
sleep disorders, stomach upset, hypertension, and alcohol/drug interactions. This is because
of age-related changes in the body that affect how older persons react to alcohol and also
because of the age-associated increases in illness and medication use.
In the current project we aim to see if screening and brief advice given to older risky
drinkers in a physician's office followed by up to 3 health education phone calls may reduce
their risks associated with alcohol use. We plan to use a newly developed and tested
measure, the Comorbidity Alcohol Risk Evaluation Tool (CARET), to screen for older persons
(aged 55 and older) whose use of alcohol alone or in combination with their illnesses,
symptoms, and medication use may be causing them harm, or increasing their risk for harm.
Persons whose responses on the CARET indicate they might be risky drinkers will be
randomized to receive either a brief intervention to reduce their risks or usual care.
The intervention will have the following components:
A) At the time of the recruitment visit, all intervention group patients will receive:
1. A personalized risk report;
2. An educational booklet titled "Healthy Drinking as You Age";
3. A drinking diary;
4. Brief advice to reduce their drinking by their physicians;
B) After the recruitment visit, all intervention group patients will receive up to 3
telephone calls from a health educator. After each call, intervention group patients may
choose to receive a letter updating their health risks. Also, at the conclusion of their
interaction with the health educator, they may choose to have a letter summarizing the calls
sent to their physician.
At the time of the recruitment visit, control group patients will receive a booklet on a
variety of healthy behaviors titled "Healthy Living as You Age." Both control and
intervention group patients will receive a telephone call from a research associate 3 months
and 12 months after initial enrollment in the study to administer the CARET again.
We will analyze our results to look for differences between the intervention and control
groups at 12 months in the a) proportions of them identified as risky drinkers by the CARET;
b) the amount they drink; c) the numbers of risks identifying those persons who are still
risky drinkers and d) the difference in their expectations regarding aging.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01539954 -
Computerized Alcohol Screening for Children and Adolescents
|
N/A | |
Completed |
NCT01544218 -
Validating NIAAA Screen Guide in YCMC
|
N/A | |
Active, not recruiting |
NCT01655615 -
Does Delaying Adolescent Substance Use Lead to Improved Cognitive Function and Reduce Risk for Addiction?
|
N/A | |
Completed |
NCT00202514 -
Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
|
Phase 2/Phase 3 | |
Completed |
NCT00427206 -
Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing
|
Phase 4 | |
Completed |
NCT00132262 -
Brief Intervention to Reduce Injury in Minorities
|
N/A | |
Completed |
NCT02407340 -
Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder
|
Phase 1 | |
Completed |
NCT00734656 -
Pharmacogenetics of Alcohol: Treatment Implications
|
N/A | |
Completed |
NCT00402571 -
Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics
|
Phase 4 | |
Completed |
NCT00802321 -
Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects
|
N/A |